KPV: alpha-MSH-derived anti-inflammatory tripeptide
Medically reviewed by: Op. Dr. Ferhat İlen, ENT – Head & Neck Surgeon · Last updated:
KPV consists of the terminal three amino acids of alpha-melanocyte-stimulating hormone (α-MSH). In vitro and animal models have demonstrated its effects in reducing intestinal inflammation.
Regulatory / evidence status: At the preclinical (laboratory/animal) stage; lacks human clinical trials and regulatory drug approval.
What do we know?
It has been reported to suppress the NF-κB pathway and alleviate inflammation in colitis models. Clinical data in humans are not available.
Fi Life approach
For gastrointestinal symptoms, a diagnostic workup, microbiome evaluation, and tailored nutritional strategy are prioritized first.
Frequently asked questions
Does KPV cause tanning like melanotan?
No; it does not contain the sequence responsible for stimulating pigmentation.
References
This page is for information only and does not replace diagnosis, treatment advice or a prescription. Peptide and drug assessments are made only after a physician consultation. No results are guaranteed.
Ask your physician whether it is right for you